Abstract: An asymmetric tetradentate metal complex of a N{circumflex over (?)}C{circumflex over (?)}C{circumflex over (?)}N comprising tetradentate ligand has a metal connected to binding sites which are connected to each other via three or four covalent bonds that can be either single or double bonds with bridging linkers reside between C{circumflex over (?)}C and C{circumflex over (?)}N moieties. These linkers result in three-dimension metal complexes with distorted square planar geometries. The four donor atoms coordinate to a metal center. Upon metal binding a 5-6-6 membered metallocycle is formed upon chelation including a first nitrogen donor bond, a first metal-carbon bond, a second metal-carbon bond, and a second nitrogen donor bond. The light emission from these metal complexes can be tuned by the ligand structure over the entire visible spectrum.

Abstract: Novel Pt tetradentate complexes having Pt—O bond is disclosed. These complexes are useful as emitters in phosphorescent OLEDs.

Abstract: A compound that has the structure according to Formula M(LA)x(LB)y(LC)z is disclosed. In Formula M(LA)x(LB)y(LC)z, ligand LA is ligand LB is and ligand LC is and OLEDs and formulations containing these compounds are disclosed. In Formula M(LA)x(LB)y(LC)z; M is a metal; x is 1 or 2; X1-X4 and A1-A8 are C or N; at least one of A1-A8 is N; X is O, S, or Se; two adjacent RB form a six-member aromatic ring E fused to ring B; and each RA-RE and R1R4 is independently hydrogen or a substituent.

Abstract: Novel compounds comprising heteroleptic iridium complexes are provided. The compounds have a particular combination of ligands which includes a single pyridyl dibenzo-substituted ligand. The compounds may be used in organic light emitting devices, particularly as emitting dopants, to provide devices having improved efficiency, lifetime, and manufacturing.

Abstract: A compound having a structure of formula Ir(LA)m(LB)n, where ligand LA has Formula I and ligand LB has Formula II that is useful as an emitter in OLEDs is disclosed.

Abstract: An organometallic compound represented by Formula 1, wherein M1 is beryllium, magnesium, aluminum, calcium, titanium, manganese, cobalt, copper, zinc, gallium, germanium, zirconium, ruthenium, rhodium, palladium, silver, rhenium, platinum, or gold; A1 to A3 are each independently a C5-C30 carbocyclic group or a C1-C30 heterocyclic group; A4 is a 5-membered heterocyclic group; A5 is at least two rings of a C7-C30 carbocyclic group comprising a 6-membered carbocyclic group, or A5 is at least two rings of a C1-C30 heterocyclic group comprising a 6-membered carbocyclic group or a 6-membered heterocyclic group; X10, X20, X30, and X40 to X44 are each independently C or N; T1 to T3 are each independently a single bond, *—N[(L1)a1-(R1)b1]—*?, *—B(R1)—*?, *—P(R1)—*?, *—C(R1)(R2)—*?, *—Si(R1)(R2)—*?, *—Ge(R1)(R2)—*?, *—S—*?, *—Se—*?, *—O—*?, *—C(?O)—*?, *—S(?O)—*?, *—S(?O)2—*?, *—C(R1)?C(R2)—*?, *—C(?S)—*?, or *—C?C—*?; and wherein the other substituents may be understood by referring to the detailed description.

Abstract: An organometallic compound is represented by Formula 1. An organic light-emitting device includes: a first electrode; a second electrode; and an organic layer between the first electrode and the second electrode and including an emission layer. The organic light-emitting device further includes at least one organometallic compound represented by Formula 1.

Abstract: A novel compound having a first ligand LA of is disclosed. The compound is useful as emitter dopant in OLEDs.

Abstract: An organometallic compound represented by Formula 1: wherein, in Formula 1, R1 to R12 and R16 are the same as described in the specification.

Abstract: Ligands with fused spirocyclic substitutions and metal complexes formed with such ligands and having improved performance in OLED applications are disclosed.

Abstract: An organometallic compound represented by Formula 1, an organic light-emitting device including the organometallic compound, and a diagnostic composition including the organometallic compound: M11(L11)n11(L12)n12??Formula 1 wherein, in Formula 1, M11 is a first-row transition metal, a second-row transition metal, or a third-row transition metal, L11 is a ligand represented by Formula 1-1, L12 is a monodentate ligand or a bidentate ligand, n11 is 1, and n12 is 0, 1, or 2: wherein, in Formula 1-1, Y11, A11, T11 k11, k12, k13, b11, E11 to E13 and R11 to R17 are described in the specification, and *1 to *4 each independently indicate a binding site to M11.

Abstract: An organic light-emitting material containing cyano-substituted ligand is disclosed. The organic light-emitting material is a metal complex containing a cyano-substituted ligand, which can be used as a light-emitting material in a light-emitting layer of an organic electroluminescent device. These new complexes can provide better device performance, e.g., narrower full width at half maximum, lower voltage values, and higher quantum efficiency, and the like. An electroluminescent device and a compound formulation containing the metal complex, and a compound capable of being used to prepare the metal complex are also disclosed.

Abstract: This invention relates to the development of heterocyclic materials for use as blue phosphorescent materials in OLED devices. The materials are based on a pair of 5-membered aromatic or psuedoaromatic rings bonded to one another and complexed to a transition metal. The materials were determined computationally to have appropriate triplet energies for use as blue emitters and to possess sufficient chemical stability for use in devices.

Abstract: Novel Iridium complexes having three different bidentate ligands useful for phosphorescent emitters in OLEDs are disclosed. At least one of the three different bidentate ligands is a carbene ligand.

Abstract: The present invention relates to iridium complexes suitable for use in organic electroluminescent devices, especially as emitters.

Abstract: An organometallic compound is represented by Formula 1 and an organic light-emitting device includes the same. The organic light-emitting device includes: a first; a second electrode facing the first electrode; and an organic layer between the first electrode and the second electrode and including an emission layer, wherein the organic layer includes an organometallic compound represented by Formula 1.

Abstract: Provided are organometallic compounds. Also provided are formulations comprising these organometallic compounds. Further provided are OLEDs and related consumer products that utilize these organometallic compounds.

Abstract: A compound having a formula (LA)mIr(LB)3?m having a structure selected from is disclosed. In the structures of formula (LA)mIr(LB)3-m, m is 1 or 2, R1, R2, R3, R4, and R5 are each independently selected from hydrogen, deuterium, C1 to C6 alkyl, C1 to C6 cycloalkyl, and partially or fully deuterated variants thereof, and partially or fully fluorinated variants thereof, and, R6 is selected from C1 to C6 alkyl, C1 to C6 cycloalkyl, and partially or fully deuterated variants thereof, and partially or fully fluorinated variants thereof.

Abstract: Provided is a compound of Chemical Formula 1: and to an organic light emitting device comprising the same.

Abstract: Dendrimer compositions and methods for the treatment of one or more inflammatory and/or angiogenic diseases and/or disorders of the eye include hydroxyl-terminated dendrimers complexed or conjugated with one or more active agents for the treatment or alleviation of one or more symptoms of the diseases of the eye, and/or for diagnosing the diseases and/or disorders of the eye. The dendrimers may include one or more ethylene diamine-core poly(amidoamine) (PAMAM) hydroxyl-terminated generation-4, 5, 6, 7, 8, 9, or 10 dendrimers. The active agents may be VEGFR tyrosine kinase inhibitors including sunitinib or analogues thereof. Preferably, the compositions are suitable for administration via a systemic route to target activated microglia/macrophages in retina/choroid.

Abstract: The present invention provides a thin-film forming raw material, which is used in an atomic layer deposition method, including a compound represented by the following general formula (1): where R1 to R4 each independently represent an alkyl group having 1 to 5 carbon atoms, and A1 represents an alkanediyl group having 1 to 5 carbon atoms.

Abstract: Disclosed is an organic light-emitting material including a 3-deuterium-substituted isoquinoline ligand. The organic light-emitting material is a metal complex including a 3-deuterium-substituted isoquinoline ligand and an acetylacetonate ligand, which can be used as a light-emitting material in a light-emitting layer of an organic electroluminescent device. These novel complexes can effectively prolong device lifetime. Further disclosed is an electroluminescent device including the metal complex and a compound formulation.

Abstract: A novel compound having a first ligand LA of is disclosed. The compound is useful as emitter dopant in OLEDs.

Abstract: Provided is a compound of Chemical Formula 1: wherein: among X1 to X4, one of X1 and X2, X2 and X3, or X3 and X4 are linked with * in the following Chemical Formula 2, and of the remaining two, one is hydrogen, and the other is R3: R1 and R2 are each independently hydrogen, deuterium, halogen, cyano, amino, a substituted or unsubstituted C1-60 alkyl, a substituted or unsubstituted C1-60 haloalkyl, a substituted or unsubstituted C1-60 alkoxy, a substituted or unsubstituted C1-60 haloalkoxy, a substituted or unsubstituted C3-60 cycloalkyl, a substituted or unsubstituted C2-60 alkenyl, a substituted or unsubstituted C6-60 aryl, a substituted or unsubstituted C6-60 aryloxy, or a substituted or unsubstituted C2-60 heterocyclic group containing one or more heteroatoms selected from the group consisting of N, O and S; one of R3 is hydrogen, and the other is —Si(R4)(R5)(R6), R4 to R6 are each independently hydrogen, deuterium, cyano, a substituted or unsubstituted C1-60 alkyl, a substituted or unsubst

Abstract: An organic electroluminescent device, which has a pair of electrodes and at least one organic layer including a luminescent layer between the pair of electrodes, wherein at least one layer between the pair of electrodes comprises at least one metal complex having a tridentate- or higher polydentate-chain structure ligand.

Abstract: An organometallic compound represented by Formula 1: wherein, in Formula 1, groups and variables are the same as described in the specification.

Abstract: Platinum compounds of Formulas I and II useful in a variety of devices, such as, for example organic-light emitting diodes (OLEDs).

Abstract: Tridentate platinum, palladium, and gold complexes of Formulas A-I and A-II and tridentate iridium and rhodium compounds of Formulas B-I, B-II, and B-III suitable for delayed fluorescent and phosphorescent or phosphorescent emitters in display and lighting applications.

Abstract: Novel Iridium complexes having three different bidentate ligands useful for phosphorescent emitters in OLEDs are disclosed. At least one of the three different bidentate ligands is a carbene ligand.

Abstract: Tetradentate platinum and palladium complexes based on biscarbazole and analogues for full color displays and lighting applications.

Abstract: The present invention refers to a process for transition-metal-assisted 18F-deoxyfluorination of phenols. The transformation benefits from readily available phenols as starting materials, tolerance of moisture and ambient atmosphere, large substrate scope, and translatability to generate doses appropriate for positron emission tomography (PET) imaging.

Abstract: The present invention provides a data transmitting circuit, a data receiving circuit and a data transferring apparatus. In one of the implementations of the data transmitting circuit, the first end of the primary coil of a transformer is connected to a first power supply interface, and the second end of the primary coil of the transformer is connected to the first end of a current limiting module and the first end of a first capacitor respectively; the first end of the secondary coil of the transformer is connected to a second power supply interface, and the second end of the secondary coil of the transformer is connected to a transmitting interface; the second end of the current limiting module and the second end of the first capacitor are both connected to the input end of a switch module.

Abstract: The present invention provides a method for producing a cyclometalated iridium complex, the method including producing a cyclometalated iridium complex by reacting a cyclometalated iridium complex raw material including an organoiridium compound with an aromatic heterocyclic bidentate ligand capable of forming an iridium-carbon bond and an iridium-nitrogen bond, and using as the raw material an organoiridium compound including a substructure represented by the following General Formula (1). The present invention is capable of producing a cyclometalated iridium complex with a high yield without by-production of a halogen-crosslinked iridium dimer. (in General Formula (1), Ir represents an iridium atom, and O represents an oxygen atom).

Abstract: Novel Pt tetradentate complexes having Pt—O bond is disclosed. These complexes are useful as emitters in phosphorescent OLEDs.

Abstract: Tridentate cyclometalated complexes with rigid six-membered coordination rings of General Formula I having tunable emission wavelengths in the visible range. These emitters are suitable for full color displays and lighting applications.

Abstract: An organometallic compound represented by Formula 1: wherein, in Formula 1, groups and variables are the same as described in the specification.

Abstract: A compound having the formula [LA]3-nIr[LB]n is disclosed. In the formula, LA is and LB is Formula I.

Abstract: A complex represented by Formula I: wherein: each Ar1, Ar2, Ar3, Ar4, and Ar5 present independently represents a substituted or unsubstituted aryl or heterocyclic aryl; each n is independently an integer of 0 to 4, as limited by valence; X represents O, S, NR1a, SiR1bR1c, or CR1dR1e, where each of R1a, R1b, R1c, R1d, and R1e independently represents substituted or unsubstituted C1-C4 alkyl; Y1a, Y2a, Y3b, and Y4a each independently represents N or C; Y3a represents N, CR2a, or SiR2b, where R2a and R2b represent hydrogen or substituted or unsubstituted C1-C4 alkyl, aryl, or heterocyclic aryl; Y5a and Y5b each independently represents C or N; and Y5c, Y5d, and Y5e each independently represents C, N, O, or S. Light emitting devices for full color displays may include a complex represented by Formula I.

Abstract: An organometallic compound represented by Formula 1: wherein, in Formula 1, groups and variables are the same as described in the specification.

Abstract: Synthesis of four coordinated palladium complexes and their applications in light emitting devices thereof.

Abstract: An organometallic compound represented by Formula 1: wherein, in Formula 1, groups and variables are the same as described in the specification.

Abstract: An organometallic compound represented by Formula 1: M(L1)(L2)??Formula 1 wherein, in Formula 1, M, L1, and L2 are the same as described in the specification.

Abstract: Tridentate cyclometalated complexes with rigid six-membered coordination rings of General Formula I having tunable emission wavelengths in the visible range. These emitters are suitable for full color displays and lighting applications.

Abstract: Novel organic compounds comprising ligands with deuterium substitution are provided. In particular, the compound is an iridium complex comprising methyl-d3 substituted ligands. The compounds may be used in organic light emitting devices to provide devices having improved color, efficiency and lifetime.

Abstract: Synthesis of four coordinated palladium complexes and their applications in light emitting devices thereof.

Abstract: The present invention relates to novel bis-iridium-based Ir(III) complexes, labels manufactured using these complexes and a method for producing such complexes.

Abstract: A novel Pt tetradentate complexes having Pt—O bond is disclosed. These complexes are useful as emitters in phosphorescent OLEDs.

Abstract: An object is to provide a novel organometallic complex. Another object is to provide an organometallic complex that can exhibit yellow to blue phosphorescence. A platinum complex with a tetracoordinate ligand including a phenothiazine skeleton or a phenoxazine skeleton is provided. In the ligand, nitrogen at the 10-position and carbon at the 2-position of the phenothiazine skeleton or the phenoxazine skeleton have a pyridyl group and a phenoxy group, respectively. A five-membered heteroaromatic residue is present at the 3-position of the phenoxy group. The five-membered heteroaromatic residue has two or three nitrogen atoms in its skeleton. Carbon at the 1-position of the phenothiazine skeleton or the phenoxazine skeleton and carbon at the 2-position of the phenoxy group are bonded to platinum, and nitrogen of the pyridyl group and nitrogen or carbene carbon of the five-membered heteroaromatic residue are coordinated to platinum.

Abstract: A compound containing a partial structure of Formula I: is provided. In the structure of Formula I, M is a metal with an atomic number of at least 40; RA, RB, and RC are each independently 5 or 6 membered aryl or heteroaryl rings; R1, R2, R3, and A are each independently selected from a variety of substituents and combinations thereof; A is optionally bonded to RA or RC to form a fused ring; X1 is B, C, N, O, S or Se; X2-X7 are independently B, C or N; and Y1-Y2 are independently C or N. Formulations and devices, such as an OLEDs, that include the compound containing a structure of Formula I are also described.

Abstract: An organometallic compound represented by Formula 1: wherein in Formula 1, CY1, M, L, R1, R2, R3, R4, a1, a2, n1, and n2 are described in the specification.